[Summary] 免疫治疗原创新药研发商
泽安生物医药(LTZ Therapeutics)是一家聚焦新型免疫疗法的全球一体化生物技术公司。针对癌症、自身免疫性疾病等领域的重大未满足临床需求,公司自主研发“髓系细胞衔接器”技术平台(Myeloid Engager Platform)和相关原创新药,旨在提升广大患者的综合临床获益。公司的国际化团队分布于中国深圳、美国加州红木城和德国海德堡。基于反向转化科学与新兴的肿瘤微环境生物学,LTZ致力于开发既能克服耐药、又能增强抗肿瘤免疫力的新一代免疫疗法。
Congratulations, submitted successfully!
Your edit is under review. You will be notified by email within 1 business day.
Submission failed.
Help others learn about this company, add my impression of this company»
Log in with the following accounts to save your follows